Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Grazia Daidone

Showing results (21-30 of 134) with videos related to

Pageof 14
Sort By:
The International Journal of Biological Markers|April 6, 2013
Cell proliferation of the primary tumor predicts ipsilateral axillary node disease in elderly breast cancer patientsRosella Silvestrini, Gabriele Martelli, Rosalba Miceli, et al.
Journal of the National Cancer Institute. Monographs|June 12, 2015
Circulating Biomarkers for Prediction of Treatment ResponseVera Cappelletti, Valentina Appierto, Paola Tiberio, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 20, 2004
Biomolecular features of clinical relevance in breast cancerMaria Grazia Daidone, Angelo Paradiso, Massimo Gion, et al.
Bioanalysis|June 21, 2014
A lipemia-independent NanoDrop(®)-based score to identify hemolysis in plasma and serum samplesValentina Appierto, Maurizio Callari, Elena Cavadini, et al.
Seminars in Cancer Biology|April 27, 2017
How to study and overcome tumor heterogeneity with circulating biomarkers: The breast cancer caseValentina Appierto, Serena Di Cosimo, Carolina Reduzzi, et al.
International Journal of Oncology|September 25, 2008
Clusterin: a potential target for improving response to antiestrogensSara Toffanin, Maria Grazia Daidone, Patrizia Miodini, et al.
BMJ (Clinical Research Ed.)|January 15, 2005
30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort studyGianni Bonadonna, Angela Moliterni, Milvia Zambetti, et al.
Molecular Cancer Therapeutics|January 25, 2006
Silencing of survivin gene by small interfering RNAs produces supra-additive growth suppression in combination with 17-allylamino-17-demethoxygeldanamycin in human prostate cancer cellsFrancesco Paduano, Raffaella Villa, Marzia Pennati, et al.
Biopreservation and Biobanking|May 22, 2014
Integrating collection of biospecimens in clinical trials: the approach of the European organization for research and treatment of cancerJacqueline A Hall, Maria Grazia Daidone, Godefridus J Peters, et al.
The Prostate|December 24, 2002
Ribozyme-mediated inhibition of PKCalpha sensitizes androgen-independent human prostate cancer cells to cisplatin-induced apoptosisLinda Orlandi, Mara Binda, Marco Folini, et al.
Pageof 14

Showing results (21-30 of 134) with videos related to

Sort By:
Pageof 14
The International Journal of Biological Markers|April 6, 2013
Cell proliferation of the primary tumor predicts ipsilateral axillary node disease in elderly breast cancer patientsRosella Silvestrini, Gabriele Martelli, Rosalba Miceli, et al.
Journal of the National Cancer Institute. Monographs|June 12, 2015
Circulating Biomarkers for Prediction of Treatment ResponseVera Cappelletti, Valentina Appierto, Paola Tiberio, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 20, 2004
Biomolecular features of clinical relevance in breast cancerMaria Grazia Daidone, Angelo Paradiso, Massimo Gion, et al.
Bioanalysis|June 21, 2014
A lipemia-independent NanoDrop(®)-based score to identify hemolysis in plasma and serum samplesValentina Appierto, Maurizio Callari, Elena Cavadini, et al.
Seminars in Cancer Biology|April 27, 2017
How to study and overcome tumor heterogeneity with circulating biomarkers: The breast cancer caseValentina Appierto, Serena Di Cosimo, Carolina Reduzzi, et al.
International Journal of Oncology|September 25, 2008
Clusterin: a potential target for improving response to antiestrogensSara Toffanin, Maria Grazia Daidone, Patrizia Miodini, et al.
BMJ (Clinical Research Ed.)|January 15, 2005
30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort studyGianni Bonadonna, Angela Moliterni, Milvia Zambetti, et al.
Molecular Cancer Therapeutics|January 25, 2006
Silencing of survivin gene by small interfering RNAs produces supra-additive growth suppression in combination with 17-allylamino-17-demethoxygeldanamycin in human prostate cancer cellsFrancesco Paduano, Raffaella Villa, Marzia Pennati, et al.
Biopreservation and Biobanking|May 22, 2014
Integrating collection of biospecimens in clinical trials: the approach of the European organization for research and treatment of cancerJacqueline A Hall, Maria Grazia Daidone, Godefridus J Peters, et al.
The Prostate|December 24, 2002
Ribozyme-mediated inhibition of PKCalpha sensitizes androgen-independent human prostate cancer cells to cisplatin-induced apoptosisLinda Orlandi, Mara Binda, Marco Folini, et al.
Pageof 14